Anti-Cetuximab Antibody (12B1E9) (recommended for PK/PD, MALS verified), Unconjugated, Human

Produktübersicht

• Artikelname: Anti-Cetuximab Antibody (12B1E9) (recommended for PK/PD, MALS verified), Unconjugated, Human
• Artikelnummer: ABS-CEB-Y29C-100UG
• Hersteller Artikelnummer: CEB-Y29c-100ug
• Alternativnummer: ABS-CEB-Y29C-100UG
• Hersteller: AcroBiosystems
• Wirt: Human
• Kategorie: Antikörper
• Spezies Reaktivität: Mouse
• Konjugation: Unconjugated

Produktbeschreibung

Cetuximab is an epidermal growth factor receptor binding FAB. Cetuximab is composed of the Fv (variable, antigenbinding) regions of the 225 murine EGFr monoclonal antibody specific for the Nterminal portion of human EGFr with human IgG1 heavy and kappa light chain constant (framework) regions. - Antikörper

Produkteigenschaften

• Tag: Mouse IgG1 | Mouse Kappa
• Puffer: 50 mM Tris, 100 mM Glycine, 25 mM Arginine, 150 mM NaCl, pH7.5
• Reinheit: 0.9
• Formulierung: Powder
• Target-Kategorie: Cetuximab

Bilder

Immobilized Cetuximab at 1 µg/mL (100 µL/well) can bind Anti-Cetuximab Antibody (12B1E9) (Cat. No. CEB-Y29c) with a linear range of 0.2-1.6 ng/mL (QC tested).

Anti-Cetuximab Antibody (12B1E9) on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 0.9.